Tuberculosis (TB) news, resources and funding for global health researchers
A major cause of death and disability worldwide, tuberculosis is a contagious lung disease that spreads through the air when people infected with it cough, sneeze, talk or spit. TB is caused by a bacterium called
Mycobacterium tuberculosis, which usually attacks the lungs, but can affect other parts of the body like the kidney, spine and brain. The disease can be fatal if not treated properly.
According to the World Health Organization, there are almost 2 million TB-related deaths each year, and more than 9 million people around the world become sick with the disease annually. In 2009, almost 10 million children were orphaned as a result of parental deaths caused by TB. The spread of multidrug-resistant TB is a growing global threat, with hundreds of thousands of new cases emerging each year.
TB coinfection with HIV/AIDS is also a serious health issue and a leading cause of death worldwide among people with HIV. Several NIH research and research training programs are helping to reduce the impact of tuberculosis both in the U.S. and overseas.
Grant Awards Related to TB
Recent News
- The lived experiences of tuberculosis survivors during the COVID-19 pandemic and government lockdown in South Africa: a qualitative analysis, co-authored by Fogarty fellow Ann Scheunemann
BMC Public Health, September 5, 2023
-
TB drug interactions among people living with HIV in Uganda
Global Health Matters, July/August 2023 -
Investigational Three-Month TB Regimen Is Safe but Ineffective, NIH Study Finds
NIH/NIAID news, July 5, 2023 -
Human testing for potential new TB treatment, first in nearly six decades profile of Fogarty Emerging Global Leader Admire Dube
Nature Africa, June 27, 2023 -
Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study
NIH/NIAID news, March 6, 2023 -
WHO announces plans to establish a TB Vaccine Accelerator council
WHO news, January 17, 2023 -
Tackling tobacco, TB, and mental health in South Africa
Nov/Dec 2022
Global Health Matters -
Tuberculosis deaths and disease increase during the COVID-19 pandemic
WHO news, October 27, 2022
-
Treatment for drug-resistant TB still effective with lower dosage and fewer side effects
Sept/Oct 2022,
Global Health Matters
NIH News and Resources
Other US Government Resources
- Centers for Disease Control and Prevention (CDC):
- U.S. Agency for International Development (USAID):Tuberculosis
Other Online Resources
Updated September 18, 2023